- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03424434
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017 (OBE PRACTITIONERS UHC 2017)
Underreporting of Occupational Blood Exposure (OBE) Among Medical Staff at an University Hospital Center (UHC) in 2017
Study Overview
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- CHU Clermont-Ferrand
-
La Tronche, France, 38700
- Chu Grenoble Alpes
-
Pierre-Bénite, France, 69495
- Groupement Hospitalier Sud
-
Saint-Étienne, France, 42055
- CHU de Saint-Etienne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any medical or surgical health professional
- practitioner and resident
- working in an UHC
- without distinction of medical or surgical specialty
- having a professional mailbox
Exclusion Criteria:
- All paramedical health professionals (example: nurses) and pharmacists
- Any medical or surgical health professional working full-time outside an UHC
- Any medical or surgical health professional with exclusive liberal activity outside an UHC
- Administrative and technical staff of an UHC
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Medical staff of an UHC, practitioners and residents
The target population is practitioners and residents who works at hospital in an UHC, they are also specialists, surgeons, dental surgeons.
|
The study consists in a survey diffusion during several weeks by emailing each practitioner and resident and inviting them to participate to a questionnaire about occupational blood exposure.
This survey is strictly anonymous.
No identity data is required, only age, gender, function, surgical or medical specialty, work quota and hospital group they belong.
This survey is diffused in four UHC (Lyon, Grenoble, Clermont-Ferrand and Saint-Etienne) in France.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of underreporting occupational blood exposure (OBE) among the medical staff at an University Hospital Center (UHC) for the year 2017
Time Frame: 1 day
|
This evaluation consists in collecting, during the diffusion of a survey, the number of OBE the medical professional is victim of and the number of OBE is reported to deduce the number of non-reported OBE, over the period of interest which is the year 2017.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The occurrence circumstances of OBE
Time Frame: 1 day
|
These questions are gathered in a table and concern different sorts of contaminated needlesticks, blood projections, cut or wound and the positive serologic status for the source patient. This specific outcome is qualitatively evaluated with questions relating to the occurence circumstances of OBE with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
The part of each factor, related to the professional activity and to the OBE itself, in the OBE reporting.
Time Frame: 1 day
|
Some questions are gathered in a table and propose 15 differents reasons that can condition the OBE reporting, such as lack of time, fear of judgment, repetition of OBE, unknowing of reporting procedure, lack of standards precautions, only antisepsis maneuvers sufficient, source patient considered as safe, procedure to report considered complex, fear of career consequences, lack of witness, night work, negatives serologies for the source patient, fear of the serological follow-up, fear observing an antiretroviral treatment, ignorance that an OBE was a true one. For each factor, a percentage will be measured as indicative of its importance in the OBE underreporting. This specific outcome considering various factors that can influence the reporting of an OBE is evaluated by several questions with a yes or no answer. |
1 day
|
|
Involvement of behaviors of underreporting medical professionals
Time Frame: 1 day
|
Using two tables, several measures recommanded about the biological risk in hospital environment (including OBE) are discussed. These differents measures are considered as primary and secondary preventive behaviors. For each measure, we examine its frequency as indicative of its implication in the OBE underreporting. This outcome is evaluated with questions on vaccination, immunization, wearing of personal protective equipment and realization of the antisepsis maneuvers, realization of serologies for source patient and personal ones, with a choice of standards answers (Yes, always - Often - Sometimes - No, never). |
1 day
|
|
Practitioners knowledges about the specific infectious risk of OBE
Time Frame: 1 day
|
On a first table, the participant has to choose one of the four rates proposed (30% - 1 to 3% - 0,3% - < 0,3%) to evaluate the risk of seroconversion after percutaneous contact with infected blood by HIV or hepatitis B virus (HBV) or hepatitis C virus (HCV). On a second table, the participant has to choose a time limit (Immediately - within 4 hours - within 48 hours - up to 7 days) for different situations near OBE occurence, it concerns antisepsis maneuvers, prophylactic antiretroviral treatment, initial personal serological status and source patient serological status. A test is proposed to evaluate knowledges about the infectious risk related to OBE, this test is optional, grouping together seven simple choice questions. |
1 day
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL17_0883
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Professional
-
Alexandria UniversityBenha UniversityCompletedUndergraduate Health Professional StudentsEgypt
-
Ankara UniversityNot yet recruitingHealth Communication | Professional CompetenceTurkey (Türkiye)
-
Fondazione Don Carlo Gnocchi OnlusCompletedUndergraduate Health Professional StudentsItaly
-
University of Roma La SapienzaRecruitingSocial Media | Health Communication | Professional EthicsItaly
-
Universidad de ZaragozaRecruitingProfessional Integration of Newly Graduated Occupational Therapists | Peer Mentorship in Health Professions | Early Career Transition and Professional IdentitySpain
-
West University of TimisoaraCompletedMental Health Wellness | Professional BurnoutRomania
-
Assistance Publique - Hôpitaux de ParisUniversità degli Studi di Trento; Czech Technical University in Prague; Institut... and other collaboratorsCompletedPatient Participation | Professional Role | Patient Relations, NurseFrance
-
Isparta University of Applied SciencesSuleyman Demirel UniversityRecruitingStudents | Educational Technology | Physiotherapy and Rehabilitation | Undergraduate Health Professional Students | Educational InterventionsTurkey (Türkiye)
-
Kırıkkale UniversityCompletedHealth Personnel Attitude | Job Satisfaction | Professional BurnoutTurkey
-
Izmir Democracy UniversityEge UniversityCompletedEducation | Professional Role | Interprofessional Relations | Patient Acceptance of Health Care | Patient Safety | Acceptability of Health CareTurkey
Clinical Trials on Survey diffusion
-
University of Michigan Rogel Cancer CenterTerminatedDiffuse Large B Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterRecruitingMetastatic Malignant Neoplasm in the Liver | Metastatic Colorectal Carcinoma | Stage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Resectable Colorectal CarcinomaUnited States
-
Corewell Health EastNational Cancer Institute (NCI); University of Iowa; Oregon Health and Science... and other collaboratorsRecruiting
-
Bezmialem Vakif UniversityMuğla Sıtkı Koçman University; The Scientific and Technological Research Council... and other collaboratorsActive, not recruitingEating Disorders | Eating Behavior | Orthodontic Appliance Complication | Eating HabitTurkey
-
Assiut UniversityUnknown
-
Chinese University of Hong KongActive, not recruitingMultiple SclerosisHong Kong
-
Peking University Third HospitalEnrolling by invitation
-
University of British ColumbiaPediatric Orthopaedic Society of North AmericaUnknown
-
BraintaleNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisUnknownHearing Loss | Encephalopathy | SUSAC's Syndrome | Retinal Artery Branch OcclusionsFrance